| Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria AJ Thompson, BL Banwell, F Barkhof, WM Carroll, T Coetzee, G Comi, ... The Lancet Neurology 17 (2), 162-173, 2018 | 7530 | 2018 |
| Consistent resting-state networks across healthy subjects JS Damoiseaux, SARB Rombouts, F Barkhof, P Scheltens, CJ Stam, ... Proceedings of the national academy of sciences 103 (37), 13848-13853, 2006 | 5102 | 2006 |
| Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration JM Wardlaw, EE Smith, GJ Biessels, C Cordonnier, F Fazekas, R Frayne, ... The Lancet Neurology 12 (8), 822-838, 2013 | 5018 | 2013 |
| Defining the clinical course of multiple sclerosis: the 2013 revisions FD Lublin, SC Reingold, JA Cohen, GR Cutter, PS Sørensen, ... Neurology 83 (3), 278-286, 2014 | 4000 | 2014 |
| Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis JA Cohen, F Barkhof, G Comi, HP Hartung, BO Khatri, X Montalban, ... New England Journal of Medicine 362 (5), 402-415, 2010 | 2859 | 2010 |
| A new rating scale for age-related white matter changes applicable to MRI and CT LO Wahlund, F Barkhof, F Fazekas, L Bronge, M Augustin, M Sjogren, ... Stroke 32 (6), 1318-1322, 2001 | 2149 | 2001 |
| Atrophy of medial temporal lobes on MRI in" probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. P Scheltens, D Leys, F Barkhof, D Huglo, HC Weinstein, P Vermersch, ... Journal of Neurology, Neurosurgery & Psychiatry 55 (10), 967-972, 1992 | 2015 | 1992 |
| Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. F Barkhof, M Filippi, DH Miller, P Scheltens, A Campi, CH Polman, ... Brain: a journal of neurology 120 (11), 2059-2069, 1997 | 1818 | 1997 |
| Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study G Comi, M Filippi, F Barkhof, L Durelli, G Edan, O Fernández, HP Hartung, ... The Lancet 357 (9268), 1576-1582, 2001 | 1492 | 2001 |
| Reduced resting-state brain activity in the “default network” in normal aging JS Damoiseaux, CF Beckmann, EJS Arigita, F Barkhof, P Scheltens, ... Cerebral cortex 18 (8), 1856-1864, 2008 | 1456 | 2008 |
| A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging P Scheltens, F Barkhof, D Leys, JP Pruvo, JJP Nauta, P Vermersch, ... Journal of the neurological sciences 114 (1), 7-12, 1993 | 1140 | 1993 |
| MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines M Filippi, MA Rocca, O Ciccarelli, N De Stefano, N Evangelou, L Kappos, ... The Lancet Neurology 15 (3), 292-303, 2016 | 1087 | 2016 |
| Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes L Kappos, CH Polman, MS Freedman, G Edan, HP Hartung, DH Miller, ... Neurology 67 (7), 1242-1249, 2006 | 1028 | 2006 |
| STandards for ReportIng Vascular changes on nEuroimaging (STRIVE v1). Neuroimaging standards for research into small vessel disease and its contribution to ageing and … JM Wardlaw, EE Smith, GJ Biessels, C Cordonnier, F Fazekas, R Frayne, ... Lancet Neurol 12 (8), 822-838, 2013 | 996 | 2013 |
| Cortical lesions in multiple sclerosis D Kidd, F Barkhof, R McConnell, PR Algra, IV Allen, T Revesz Brain 122 (1), 17-26, 1999 | 971 | 1999 |
| Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis D Miller, F Barkhof, X Montalban, A Thompson, M Filippi The Lancet Neurology 4 (5), 281-288, 2005 | 965 | 2005 |
| Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy TA Yousry, EO Major, C Ryschkewitsch, G Fahle, S Fischer, J Hou, ... New England Journal of Medicine 354 (9), 924-933, 2006 | 963 | 2006 |
| Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial L Kappos, D Li, PA Calabresi, P O'Connor, A Bar-Or, F Barkhof, M Yin, ... The Lancet 378 (9805), 1779-1787, 2011 | 957 | 2011 |
| Altered resting state networks in mild cognitive impairment and mild Alzheimer's disease: an fMRI study SARB Rombouts, F Barkhof, R Goekoop, CJ Stam, P Scheltens Human brain mapping 26 (4), 231-239, 2005 | 927 | 2005 |
| The clinico-radiological paradox in multiple sclerosis revisited F Barkhof Current opinion in neurology 15 (3), 239-245, 2002 | 916 | 2002 |